{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:44:47Z","timestamp":1767134687366,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":100,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003075.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T13:37:36Z","timestamp":1256132256000},"source":"Crossref","is-referenced-by-count":9,"title":["Treatment of hypertension in peripheral arterial disease"],"prefix":"10.1002","author":[{"given":"Deirdre A","family":"Lane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD003075.pub2-BIB1|cit1","first-page":"354","article-title":"Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands","volume":"60","author":"Hoogerbrugge","year":"2002","journal-title":"Netherlands Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB3|cit3","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large simple randomised trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","year":"1996","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(94)90022-1","article-title":"ACE-inhibition with perindopril in essential hypertensive patients with comcomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group","volume":"97","author":"Overlack","year":"1994","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0735-1097(98)00100-4","article-title":"Effect of high dose verapamil on restenosis after peripheral angioplasty","volume":"31","author":"Schweizer","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD003075.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0197-2456(95)00154-9","article-title":"Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial","volume":"17","author":"Estacio","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.0000049640.46039.52","article-title":"Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes","volume":"107","author":"Mehler","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/HJH.0b013e3282f8e3b6","article-title":"Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients","volume":"26","author":"Ahimastos","year":"2008","journal-title":"Journal of Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD003075.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-144-9-200605020-00009","article-title":"Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial","volume":"144","author":"Ahimastos","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.HYP.0000168945.44069.aa","article-title":"Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture","volume":"45","author":"Ahimastos","year":"2005","journal-title":"Hypertension"},{"issue":"9489","key":"10.1002\/14651858.CD003075.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00004872-200106000-00020","article-title":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators","volume":"19","author":"Sever","year":"2001","journal-title":"Journal of Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD003075.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/000331978803901103","article-title":"Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound","volume":"39","author":"Bernardi","year":"1988","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.eurheartj.a061440","article-title":"Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication","volume":"4","author":"Bogaert","year":"1983","journal-title":"European Heart Journal"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003075.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/000331978603700302","article-title":"The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication","volume":"37","author":"Bostrom","year":"1986","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB19|cit19","first-page":"21","article-title":"Randomised double-blind two parallel-groups ifenprodil tartrate versus placebo-controlled trial in stage II peripheral arterial occlusive disease","volume":"20","author":"Branchereau","year":"1995","journal-title":"Journal des Maladies Vasculaires"},{"issue":"12 Pt 2","key":"10.1002\/14651858.CD003075.pub2-BIB20|cit20","first-page":"2113","article-title":"Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"16","author":"Brown","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003075.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199700131-00017","article-title":"Antihypertensive efficacy of amlodipine and enalapril and effects on peripheral blood flow in patients with essential hypertension and intermittent claudication","volume":"13 Suppl 1","author":"Casiglia","year":"1997","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD003075.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1177\/000331978904001004","article-title":"Clinical efficacy of picotamide in long-term treatment of intermittent claudication","volume":"40","author":"Coto","year":"1989","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB23|cit23","first-page":"133","article-title":"A comparative trial of ketanserin and nifedipine in hypertension and obstructive peripheral arteriopathy","volume":"8","author":"Coto","year":"1991","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD003075.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000176008","article-title":"The effects of tertatolol on lipid profile","volume":"83 Suppl 1","author":"Diehm","year":"1993","journal-title":"Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.72.6.1226","article-title":"Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease","volume":"72","author":"Hiatt","year":"1985","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD003075.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5694\/j.1326-5377.1982.tb124145.x","article-title":"Beta-adrenergic blockade and peripheral vascular disease","volume":"1","author":"Ingram","year":"1982","journal-title":"Medical Journal of Australia"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ahj.2008.02.023","article-title":"Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy","volume":"156","author":"Bangalore","year":"2008","journal-title":"American Heart Journal"},{"issue":"21","key":"10.1002\/14651858.CD003075.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril Study (INVEST): an internet-based randomized trial in coronary artery disease patients with hypertension","volume":"32","author":"Pepine","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/clc.4960280704","article-title":"Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST)","volume":"28","author":"Zineh","year":"2005","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD003075.pub2-BIB31|cit31","first-page":"570","article-title":"The alpha and beta blocker carvediol in the treatment of hypertensive patients with POAD","volume":"15","author":"Kalus","year":"1995","journal-title":"Clinical Hemorheology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB32|cit32","first-page":"70","article-title":"Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease","volume":"98","author":"Klieber","year":"1986","journal-title":"Weiner Klinische Wochenschrift"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB33|cit33","first-page":"288","article-title":"Medical treatment of occlusive arterial disease of the legs. Walking exercise and medically induced hypertension","volume":"6","author":"Larsen","year":"1969","journal-title":"Angiologica"},{"issue":"8","key":"10.1002\/14651858.CD003075.pub2-BIB34|cit34","first-page":"987","article-title":"Haemodynamic effects of chronic treatment by cilazapril in normotensive patients with obliterative arterial disease of the lower limbs","volume":"87","author":"Laurent","year":"1994","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00003246-199505000-00011","article-title":"Invasive haemodynamic evaluation of sublingual captopril and nifedipine in patients with arterial hypertension after abdominal aortic surgery","volume":"23","author":"Leeman","year":"1995","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1475-097X.1983.tb00696.x","article-title":"Effect of long term beta-adrenergic-blockade on calf blood flow in hypertensive patients","volume":"3","author":"Lepantalo","year":"1983","journal-title":"Clinical Physiology"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1475-097X.1984.tb00803.x","article-title":"Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa","volume":"4","author":"Lepantalo","year":"1984","journal-title":"Clinical Physiology"},{"key":"10.1002\/14651858.CD003075.pub2-BIB39|cit38","first-page":"1","article-title":"Beta blockade and intermittent claudication","volume":"700","author":"Lepantalo","year":"1985","journal-title":"Acta Medica Scandinavica. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB40|cit39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/clpt.1985.3","article-title":"Chronic effects of labetolol, pindolol and propranolol on calf blood flow in intermittent claudication","volume":"37","author":"Lepantalo","year":"1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB38|cit40","first-page":"135","article-title":"Adrenoreceptor blocking drugs and cold feet in intermittent claudication","volume":"15","author":"Lepantalo","year":"1986","journal-title":"Vasa"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0954-6820.1985.tb08821.x","article-title":"Does beta-blockade provoke intermittent claudication?","volume":"218","author":"Lepantalo","year":"1985","journal-title":"Acta Medica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB42|cit42","first-page":"72","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial [Russian]","volume":"48","author":"Liakishev","year":"2008","journal-title":"Kardiologiia"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00005344-199606000-00004","article-title":"A dose-effect study of beraprost sodium in intermittent claudication","volume":"27","author":"Lievre","year":"1996","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7 (Part 1)","key":"10.1002\/14651858.CD003075.pub2-BIB44|cit44","first-page":"705","article-title":"The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group","volume":"10","author":"Dahl\u00f6f","year":"1997","journal-title":"American Journal of Hypertension"},{"issue":"9311","key":"10.1002\/14651858.CD003075.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1358863X9700200103","article-title":"Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease","volume":"2","author":"Liu","year":"1997","journal-title":"Vascular Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/080370598437394","article-title":"The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design","volume":"7","author":"Mann","year":"1998","journal-title":"Blood Pressure"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB48|cit48","first-page":"339","article-title":"Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled mulit-centre trial","volume":"38","author":"Natali","year":"1989","journal-title":"Annales de Cardiologie et d'Angeiologie"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB49|cit49","first-page":"229","article-title":"Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension","volume":"4","author":"Novo","year":"1985","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB50|cit50","first-page":"199","article-title":"Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs","volume":"6","author":"Novo","year":"1986","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB51|cit51","first-page":"169","article-title":"Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication","volume":"15","author":"Novo","year":"1996","journal-title":"International Angiology"},{"issue":"15","key":"10.1002\/14651858.CD003075.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","article-title":"Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND) trials","volume":"148","author":"Teo","year":"2004","journal-title":"American Heart Journal"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD003075.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0895-7061(01)02048-9","article-title":"Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial","volume":"15","author":"Kostis","year":"2002","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB55|cit55","first-page":"83","article-title":"Efficacy and tolerability of celiprolol and enalapril in patients with essential hypertension","volume":"5","author":"Panzner","year":"1992","journal-title":"Journal of Drug Development"},{"issue":"9627","key":"10.1002\/14651858.CD003075.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cpt1975175612","article-title":"Controlled trial of propranolol in intermittent claudication","volume":"17","author":"Reichert","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"8560","key":"10.1002\/14651858.CD003075.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(87)92441-X","article-title":"Placebo-controlled comparison of captopril, atenolol, labetalol and pindolol in hypertension complicated by intermittent claudication","volume":"2","author":"Roberts","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub2-BIB59|cit59","first-page":"631P","article-title":"Double-blind comparison of captopril or nifedepine in hypertension complicated by intermittent claudication","volume":"25","author":"Roberts","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD003075.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/000331979204300905","article-title":"Double-blind comparison of captopril with nifedepine in hypertension complicated by intermittent claudication","volume":"43","author":"Roberts","year":"1992","journal-title":"Angiology"},{"issue":"33","key":"10.1002\/14651858.CD003075.pub2-BIB61|cit61","first-page":"2071","article-title":"Ifenprodil tartrate for the treatment of chronic obliterating arteriosclerosis of the lower limbs with intermittent claudication. A multicentre, prospective, randomised, double-blind trial versus placebo","volume":"65","author":"Rouffy","year":"1989","journal-title":"Semaines des Hopitaux"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB62|cit62","first-page":"193","article-title":"Are beta-blockers always contraindicated in peripheral arterial occlusive disease?","volume":"85","author":"Schweizer","year":"1996","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB63|cit63","first-page":"43","article-title":"Beta blockers and nitrates in patients with peripheral arterial occlusive disease: long term findings","volume":"26","author":"Schweizer","year":"1997","journal-title":"Vasa"},{"key":"10.1002\/14651858.CD003075.pub2-BIB64|cit64","first-page":"76","article-title":"Treatment and monitoring of obstructive peripheral arterial disease in elderly with systolic hypertension","volume":"12","author":"Siniscalchi","year":"1993","journal-title":"International Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00005344-198201000-00002","article-title":"Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication","volume":"4","author":"Smith","year":"1982","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"6810","key":"10.1002\/14651858.CD003075.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/bmj.303.6810.1100","article-title":"Beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedepine and their combination","volume":"303","author":"Solomon","year":"1991","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB67|cit67","first-page":"23","article-title":"Angiotensin-converting enzyme inhibition with cilazapril does not improve blood flow, walking time, or plasma lipids in patients with intermittent claudication","volume":"4","author":"Spence","year":"1993","journal-title":"Journal of Vascular Medicine and Biology"},{"issue":"17","key":"10.1002\/14651858.CD003075.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"32E","DOI":"10.1016\/0002-9149(93)90950-H","article-title":"A new trial of the efficacy, tolerability and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS)","volume":"71","author":"Stumpe","year":"1993","journal-title":"American Journal of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD003075.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"50E","DOI":"10.1016\/S0002-9149(99)80505-0","article-title":"Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT","volume":"76","author":"Stumpe","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD003075.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.26.8.1319","article-title":"Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension","volume":"26","author":"Sutton-Tyrell","year":"1995","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD003075.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0954-6820.1985.tb08792.x","article-title":"Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication?","volume":"693","author":"Svendsen","year":"1985","journal-title":"Acta Medica Scandinavica. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0954-6820.1986.tb03293.x","article-title":"The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication","volume":"219","author":"Svendsen","year":"1986","journal-title":"Acta Medica Scandinavica"},{"issue":"9426","key":"10.1002\/14651858.CD003075.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003075.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/080370598437394","article-title":"The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design","volume":"7","author":"Mann","year":"1998","journal-title":"Blood Pressure"},{"issue":"11","key":"10.1002\/14651858.CD003075.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","article-title":"Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial","volume":"24","author":"Zanchetti","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub2-BIB76|cit76","first-page":"357","article-title":"The influence of chronic treatment with betablockade and angiotensin converting enzyme inhibition on the peripheral blood flow in hypertensive patients with and without concomitant intermittent claudication. A comparative cross-over trial","volume":"23","author":"Ven","year":"1994","journal-title":"Vasa"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub2-BIB77|cit77","first-page":"1058","article-title":"Percutaneous transluminal angioplasty vs reconstructive renovascular surgery in atherosclerotic unilateral renal artery stenosis - a prospective randomised study","volume":"15","author":"Weibull","year":"1992","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB78|cit78","first-page":"32","article-title":"Localisation and risk factors of peripheral arterial occlusive disease in the female","volume":"8","author":"Bauwens","year":"1989","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB79|cit79","first-page":"233","article-title":"Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population","volume":"13","author":"Binaghi","year":"1994","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1047-2797(96)00148-2","article-title":"Intermittent claudication in 8343 men and 21-year specific mortality follow-up","volume":"7","author":"Bowlin","year":"1997","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD003075.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005344-199219001-00006","article-title":"Different vasodilating mechanisms - different peripheral effects?","volume":"19 Suppl 1","author":"Breckenridge","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/PL00013161","article-title":"Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong","volume":"23","author":"Cheng","year":"1999","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD003075.pub2-BIB83|cit83","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD003075.pub2-BIB84|cit84","first-page":"491","article-title":"Surgical treatment for peripheral vascular disease","volume":"5\/6","author":"Fontaine","year":"1954","journal-title":"Helvetica Chirurgica Acta"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.aje.a116294","article-title":"Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study","volume":"135","author":"Fowkes","year":"1992","journal-title":"American Journal of Epidemiology"},{"issue":"9B","key":"10.1002\/14651858.CD003075.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"35J","DOI":"10.1016\/S0002-9149(97)00837-0","article-title":"Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period","volume":"80","author":"Hjalmarson","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB87|cit87","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large simple randomised trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","year":"1996","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0890-5096(06)60789-9","article-title":"An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease","volume":"2","author":"Johnston","year":"1988","journal-title":"Annals of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0033-0620(74)90034-6","article-title":"Role of blood pressure in cardiovascular morbidity and mortality","volume":"17","author":"Kannel","year":"1974","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1358863X9600100111","article-title":"The demographics of claudication and the aging of the American population","volume":"1","author":"Kannel","year":"1996","journal-title":"Vascular Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jhh.1001209","article-title":"Peripheral vascular disease and hypertension: a forgotten association?","volume":"15","author":"Makin","year":"2001","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/95.4.199","article-title":"Peripheral vascular disease and Virchow's triad for thrombogenesis","volume":"95","author":"Makin","year":"2002","journal-title":"QJM"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.ATV.18.7.1108","article-title":"Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"18","author":"McGill","year":"1998","journal-title":"Arteriosclerosis Thrombosis & Vascular Biology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub2-BIB94|cit94","first-page":"218","article-title":"Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation","volume":"11","author":"Novo","year":"1992","journal-title":"International Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD003075.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.jhh.1000917","article-title":"Guidelines for management of hypertension: report of the third working party of the British Hypertension Society","volume":"13","author":"Ramsay","year":"1999","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.0954-6820.1982.tb01939.x","article-title":"Prevalence of intermittent claudication and its effect on mortality","volume":"211","author":"Reunanen","year":"1982","journal-title":"Acta Medica Scandinavica"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003075.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00005344-198608005-00007","article-title":"Evidence of early changes of the brachial artery circulation in borderline hypertension","volume":"8","author":"Simon","year":"1986","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD003075.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(95)05657-2","article-title":"Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study","volume":"120","author":"Violi","year":"1996","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub2-BIB100|cit100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003075","article-title":"Treatment of hypertension in peripheral arterial disease","author":"Lip","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003075.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T00:00:00Z","timestamp":1386115200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003075.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T03:11:11Z","timestamp":1710645071000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003075.pub2"}},"subtitle":[],"editor":[{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":100,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003075.pub2","relation":{},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}